Jpmorgan Chase & CO Green Light Biosciences Holdings, Pbc Transaction History

Jpmorgan Chase & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.18 - $0.48 $10,578 - $28,209	-58,769 Reduced 85.01%	10,361 $3,000
Q1 2023 May 18, 2023	BUY	$0.34 - $1.19 $23,283 - $81,492	68,481 Added 10551.77%	69,130 $29,000
Q1 2023 May 11, 2023	SELL	$0.34 - $1.19 $17,102 - $59,858	-50,301 Reduced 98.73%	649 $0
Q4 2022 Feb 13, 2023	SELL	$1.03 - $2.0 $15,759 - $30,600	-15,300 Reduced 23.09%	50,950 $59,000
Q3 2022 Nov 14, 2022	BUY	$0.42 - $3.92 $15,025 - $140,234	35,774 Added 117.38%	66,250 $154,000
Q2 2022 Aug 11, 2022	BUY	N/A	28,670 Added 1587.49%	30,476 $68,000
Q1 2022 May 11, 2022	BUY	N/A	1,806 New	1,806 $17,000

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.